Pegsebrenatide (NLY01) is a long-acting GLP-1R agonist. Pegsebrenatide has an extended half-life and favorable blood-brain barrier penetration. Pegsebrenatide can block A1 astrocyte transformation, reducing dopaminergic cell death, and improving motor symptoms in mouse models of PD[1].
Purity:
95.50
CAS Number:
[2243292-26-2]
Formula:
C206H318N54O69S2(C2H4O)m+2n, m~10, n~20
Target:
GCGR
Application Notes:
Peptides
* VAT and and shipping costs not included. Errors and price changes excepted
